Effects of resistin on skeletal glucose metabolism

被引：12

作者：

Li F.-P. ^{[1
]}

Li Z.-Z. ^{[1
]}

Zhang M. ^{[1
]}

Yan L. ^{[1
]}

Fu Z.-Z. ^{[1
]}

机构：

[1] Department of Endocrinology, The Second Affiliated Hospital of Sun Yat-sen University

来源：

Frontiers of Medicine in China | 2010年 / 4卷 / 3期

基金：

中国国家自然科学基金;

关键词：

insulin resistance; resistin; skeletal muscle;

D O I：

10.1007/s11684-010-0091-9

中图分类号：

学科分类号：

摘要：

Resistin is an adipokine highly related to insulin resistance (IR). The purpose of our research was to investigate how resistin influences skeletal glucose metabolism and explore its mechanisms. We constructed the recombinant plasmid pcDNA3.1 expressing resistin and then transfected it into C2C12 myocytes. The expression of resistin in C2C12 myocytes was detected by Western blotting. Glucose uptake was measured by 3H labeled glucose; glucose oxidation and glycogen synthesis was detected with 14C-labeled glucose. GLUT4 mRNA was measured by reverse transcription polymerase chain reaction (RT-PCR). We observed that resistin was expressed in transfected myocytes, and resistin decreased insulin induced glucose uptake rate by 28%-31% and inhibited the expression of GLUT4 mRNA. However, there was no significant difference in basal glucose uptake, and glucose oxidation and glycogen synthesis remained unchanged in all groups. It is concluded that resistin inhibits insulin induced glucose uptake in myocytes by downregulating the expression of GLUT4 and it has no effects on glucose oxidation and glycogen synthesis. Our findings may provide a clue to understand the roles of resistin in the pathogenesis of skeletal IR. © 2010 Higher Education Press and Springer-Verlag Berlin Heidelberg.

引用

页码：329 / 335

页数：6

共 23 条

[1]

Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A., The hormone resistin links obesity to diabetes, Nature, 409, 6818, pp. 307-312, (2001)

[2]

Petersen K.F., Dufour S., Savage D.B., Bilz S., Solomon G., Yonemitsu S., Cline G.W., Befroy D., Zemany L., Kahn B.B., Papademetris X., Rothman D.L., Shulman G.I., The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome, Proc Natl Acad Sci U S A, 104, 31, pp. 12587-12594, (2007)

[3]

Hausdorff S.F., Fingar D.C., Morioka K., Garza L.A., Whiteman E.L., Summers S.A., Birnbaum M.J., Identification of wortmannin sensitive targets in 3T3-L1adipocytes, J Biol Chem, 274, 35, pp. 24677-24684, (1999)

[4]

Lassar A.B., Skapek S.X., Novitch B., Lassar A.B., Skapek S.K., Novitch B., Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal, Curr Opin Cell Biol, 6, 6, pp. 788-794, (1994)

[5]

Moon B., Kwan J.J., Duddy N., Sweeney G., Begum N., Resistin inhibits glucose uptake in L6 skeletal muscle cells independent of changes in insulin signaling components and Glut-4 translocation, Am J Physiol Endocrinol Metab, 285, 1, (2003)

[6]

Fan H.Q., Gu N., Liu F., Fei L., Pan X.Q., Guo M., Chen R.H., Guo X.R., Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles, Acta Pharmacol Sin, 28, 3, pp. 410-416, (2007)

[7]

Palanivel R., Maida A., Liu Y., Sweeney G., Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin, Diabetologia, 49, 1, pp. 183-190, (2006)

[8]

Pravenec M., Kazdova L., Landa V., Zidek V., Mlejnek P., Jansa P., Wang J., Qi N., Kurtz T.W., Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat, J Biol Chem, 278, 46, pp. 45209-45215, (2003)

[9]

Dietze D., Koenen M., Rohrig K., Horikoshi H., Hauner H., Eckel J., Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes, Diabetes, 51, 8, pp. 2369-2376, (2002)

[10]

Savage D.B., Sewter C.P., Klenk E.S., Segal D.G., Vidal-Puig A., Considine R.V., O'Rahilly S., Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans, Diabetes, 50, 10, pp. 2199-2202, (2001)

← 1 2 3 →